Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2020 $ 49,932 $ 373 $ 245,067 $ (147) $ (2,137) $ (193,224)
Beginning balance, shares at Jan. 31, 2020   37,303,952        
Issuance of common stock pursuant to vesting of restricted stock units   $ 5 (5)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   462,300        
Issuance of common stock pursuant to ESPP purchases 18   18      
Issuance of common stock pursuant to ESPP purchases, shares   5,702        
Issuance of common stock pursuant to exercise of stock options 119   119      
Issuance of common stock pursuant to exercise of stock options, shares   39,270        
Stock-based compensation expense 1,247   1,247      
Repurchases of common stock (80)     (80)    
Unrealized gains (losses) on marketable securities (50)       (50)  
Foreign currency translation adjustment 2,114       2,114  
Net loss (21,759)         (21,759)
Ending balance at Jan. 31, 2021 31,541 $ 378 246,446 (227) (73) (214,983)
Ending balance, shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of restricted stock units   $ 11 (11)      
Issuance of common stock pursuant to vesting of restricted stock units, shares   1,100,691        
Issuance of common stock pursuant to exercise of stock options $ 161 $ 1 160      
Issuance of common stock pursuant to exercise of stock options, shares 112,205 112,205        
Issuance of common stock, net of issuance costs $ 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,690   1,690      
Unrealized gains (losses) on marketable securities 1       1  
Foreign currency translation adjustment (901)       (901)  
Net loss (7,430)         (7,430)
Ending balance at Jan. 31, 2022 $ 42,524 $ 493 $ 265,644 $ (227) $ (973) $ (222,413)
Ending balance, shares at Jan. 31, 2022   49,347,604